Cardinal spin-off?
This article was originally published in The Gray Sheet
Executive Summary
Cardinal Health is weighing the possibility of spinning off its $5.6 billion clinical and medical products business as a separate, publicly traded company, the firm said Aug. 7. Last month, Cardinal consolidated its two major business activities of health care product sales and its $80 billion distributor operation into two distinct business units and cut 600 jobs (1"The Gray Sheet" July 21, 2008, In Brief). The clinical and medical products business includes Alaris infusion pumps, Avea respirators, Pyxis medication dispensing system, surgical gowns and gloves